Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1969 1
1970 2
1973 1
1975 2
1976 3
1977 2
1978 1
1979 3
1980 2
1981 4
1982 6
1983 7
1984 5
1985 6
1986 11
1987 10
1988 5
1989 7
1990 9
1991 8
1992 13
1993 18
1994 16
1995 13
1996 8
1997 18
1998 7
1999 10
2000 19
2001 9
2002 18
2003 16
2004 9
2005 9
2006 10
2007 11
2008 17
2009 16
2010 12
2011 18
2012 15
2013 15
2014 12
2015 13
2016 26
2017 27
2018 11
2019 16
2020 33
2021 56
2022 40
2023 33
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

623 results

Results by year

Filters applied: . Clear all
Page 1
Effectiveness of two and three doses of COVID-19 mRNA vaccines against infection, symptoms, and severity in the pre-omicron era: A time-dependent gradient.
Sukik L, Chemaitelly H, Ayoub HH, Coyle P, Tang P, Yassine HM, Al Thani AA, Hasan MR, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abdel-Rahman ME, Abu-Raddad LJ. Sukik L, et al. Among authors: coyle p. Vaccine. 2024 May 22;42(14):3307-3320. doi: 10.1016/j.vaccine.2024.04.026. Epub 2024 Apr 14. Vaccine. 2024. PMID: 38616439 Free article.
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant.
Chemaitelly H, Coyle P, Kacem MAB, Ayoub HH, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Among authors: coyle p. J Travel Med. 2024 Apr 9:taae053. doi: 10.1093/jtm/taae053. Online ahead of print. J Travel Med. 2024. PMID: 38591115
Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation.
Chemaitelly H, Ayoub HH, Tang P, Yassine HM, Al Thani AA, Hasan MR, Coyle P, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ. Chemaitelly H, et al. Among authors: coyle p. Front Med (Lausanne). 2024 Mar 11;11:1363045. doi: 10.3389/fmed.2024.1363045. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38529118 Free PMC article.
Hip-focused physical therapy versus spine-focused physical therapy for older adults with chronic low back pain at risk for mobility decline (MASH): a multicentre, single-masked, randomised controlled trial.
Hicks GE, George SZ, Pugliese JM, Coyle PC, Sions JM, Piva S, Simon CB, Kakyomya J, Patterson CG. Hicks GE, et al. Among authors: coyle pc. Lancet Rheumatol. 2024 Jan;6(1):e10-e20. doi: 10.1016/S2665-9913(23)00267-9. Lancet Rheumatol. 2024. PMID: 38258673 Clinical Trial.
623 results